In addition, we showed that higher POMP/NRF3 mRNA levels correlated significantly with lower overall survival and lower disease-free survival rates of these cancer patients (Fig. 7B and C), corroborating the importance of the NRF3-POMP axis for cancer development and colorectal cancer prognosis. The gene discussed is NFE2L3; the disease is colorectal cancer.